证券代码：603001 证券简称：奥康国际 公告编号：临 2025-037 浙江奥康鞋业股份有限公司 关于召开2025年第一次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 召开的日期时间：2025 年 12 月 30 日 14 点 30 分 (七) 涉及公开征集股东投票权 无 召开地点：浙江省永嘉县千石奥康工业园公司视频会议室 (五) 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 12 月 30 日 至2025 年 12 月 30 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通 过互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 (六) 融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 股东会召开日期：2025年12月30日 本次股东大 ...

证券代码：603001 证券简称：奥康国际 公告编号：临 2025-036 浙江奥康鞋业股份有限公司 关于公司第八届监事会第十四次会议决议的公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、审议并通过《关于取消监事会并修订<公司章程>部分条款的议案》 根据《公司法》、《关于新<公司法>配套制度规则实施相关过渡期安排》、《上 市公司章程指引（2025 年修订）》、《上海证券交易所股票上市规则》等相关法律 法规的规定，公司将不再设置监事会，监事会的职权由董事会审计委员会行使， 《监事会议事规则》相应废止；并将"股东大会"统一规范为"股东会"。 浙江奥康鞋业股份有限公司（以下简称"公司"）于 2025 年 12 月 6 日以邮 件的方式向全体监事发出第八届监事会第十四次会议通知，并于 2025 年 12 月 12 日以通讯表决方式召开。应参与表决监事 3 名，实际参与表决监事 3 名。会 议的召集和召开程序符合《中华人民共和国公司法》和《公司章程》的有关规定， 会议合法有效。 会议由监事会主席黄渊翔先生主持，经与会监事审议并 ...

证券代码：603001 证券简称：奥康国际 公告编号：临 2025-035 浙江奥康鞋业股份有限公司 关于公司第八届董事会第二十次会议决议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江奥康鞋业股份有限公司（以下简称"公司"）于 2025 年 12 月 6 日以邮 件的方式向全体董事发出第八届董事会第二十次会议通知，并于 2025 年 12 月 12 日以通讯表决方式召开。应参与表决董事 7 名，实际参与表决董事 7 名。会 议的召集和召开程序符合《中华人民共和国公司法》和《公司章程》的有关规定， 会议合法有效。 会议由董事长兼总裁王振滔先生主持，经与会董事审议并以记名投票的方式 通过了以下决议： 一、审议并通过《关于提名第九届董事会董事候选人的议案》 表决结果：7 票同意，0 票反对，0 票弃权。 鉴于公司第八届董事会任期即将届满，根据《公司法》和《公司章程》的有 关规定，公司董事会需进行换届选举。第九届董事会由八名董事组成，经公司董 事会提名委员会审查，本次董事会会议表决，同意提名王振滔先生、王进权先生、 余雄 ...

浙江奥康鞋业股份有限公司 第八届董事会提名委员会 2025 年第三次会议决议 2025 年 12 月 2 日，浙江奥康鞋业股份有限公司（以下简称"公司"）第八 届董事会提名委员会 2025 年第三次会议以通讯方式召开。全部委员出席了会议， 符合《中华人民共和国公司法》及《浙江奥康鞋业股份有限公司董事会提名委员 会议事规则》的要求。经会议审议，表决并做出如下决议： 1、审议并通过《关于提名第九届董事会董事候选人的议案》 本议案尚需提交董事会、公司股东大会审议，并实行累积投票制。其中独立 董事候选人任职资格须经上海证券交易所审核无异议后方可提交公司股东大会 审议。 表决情况：3 票赞成；0 票反对；0 票弃权。 特此决议。 浙江奥康鞋业股份有限公司 董事会提名委员会 2025 年 12 月 2 日 鉴于公司第八届董事会任期即将届满，根据《公司法》和《公司章程》的有 关规定，公司董事会需进行换届选举。公司第九届董事会由 4 名非独立董事、3 名独立董事及 1 名职工董事组成。职工董事将由公司职工代表大会选举产生，无 需提交经公司董事会及股东大会审议。经公司董事会提名委员会审查，同意提名 王振滔、王进权、余雄平、王晨 ...

不过奥康国际近三年持续亏损，同花顺（300033）数据显示，2022年至2024年，公司分别实现营业收入 27.54亿元、30.86亿元、25.39亿元，同比增速分别为-6.91%、12.05%、-17.74%；分别实现归母净利 润-3.74亿元、-0.93亿元、-2.16亿元，同比增速分别为-1199.33%、75.08%、-131.29%。而今年前三季 度，公司实现营业收入14.79亿元，同比下降21.65%；实现净利润-2.09亿元，同比下降54.02%。 全文请见：重要股东刚减持完毕再抛减持计划，奥康国际陷亏损泥潭股价却狂飙 近日，奥康国际（603001）一名重要股东再次发布最高减持3%公司股份的计划，而在12月初该名股东 刚实施完一次减持计划。值得注意的是，此前，奥康国际股价经历了一轮显著的上涨行情，在短短4个 月时间最大涨幅近150%。 ...

每经记者｜闫峰峰 每经编辑｜吴永久 近日，奥康国际一名重要股东再次发布最高减持3%公司股份的计划，而在12月初该名股东刚实施完一 次减持计划。值得注意的是，此前，奥康国际股价经历了一轮显著的上涨行情，在短短4个月时间最大 涨幅近150%。不过奥康国际近三年持续亏损，那么，在连续亏损之下，奥康国际为何还能走出较为显 著的上涨行情？对此，每经资本眼专栏记者展开了调查。 重要股东连续减持，股价4个月涨幅近150%业绩却持续亏损 2025年12月9日，奥康国际公告称，公司持股5%以上股东项今羽计划通过集中竞价和大宗交易方式减持 不超过1200万股（占公司总股本3%）。此次减持前，项今羽持股占公司总股本比例为7.14%。 虽然，公司股价自8月高点以来总体处于调整态势，不过公司股价在形态上表现出相对高位横盘的态 势，当前公司股价仍处于相对高位。截至12月10日，奥康国际收盘价报收8.98元，较4月份的低点仍有 较大涨幅。 不过，在公司股价大幅上涨的同时，公司的业绩却身陷泥潭。同花顺数据显示，2022年至2024年，公司 分别实现营业收入27.54亿元、30.86亿元、25.39亿元，同比增速分别为-6.91%、12.05 ...

Group 1 - Jinggong Technology signed a sales contract with Hubei Yuchuang worth 729 million yuan, accounting for 42.16% of the company's audited revenue for 2024 [1] - Heshun Electric is expected to win a bid for a State Grid procurement project worth 107 million yuan, representing 24.97% of the company's 2024 revenue [2] - Yongmaotai plans to invest approximately 400 million yuan in a new intelligent manufacturing project for magnesium-aluminum alloy materials [3] Group 2 - Longi Green Energy announced the termination of its plan to issue global depositary receipts abroad, stating it will not significantly impact its operations [4] - Bai Ao Intelligent is expected to win bids for projects totaling 27.5 million yuan [5] - Lian Biological is planning a change of control and asset purchase, leading to a temporary suspension of its stock [6] Group 3 - Bo Rui Communication intends to acquire 51% of Meijing Technology for 66.49 million yuan [7] - Huitai Medical plans to repurchase shares worth 200 to 250 million yuan for employee stock ownership plans [8] - Yifang Biological is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange [9] Group 4 - Jiuqiang Biological's shareholders signed an agreement for the transfer of 5% of the company's shares to China National Pharmaceutical Investment [11] - Songcheng Performing Arts plans to repurchase shares worth 100 to 200 million yuan for capital reduction [12] - Zhonghong Medical's subsidiary is expected to be selected for a centralized procurement project in Jiangxi Province [13] Group 5 - Xingfu Electronics plans to invest 480 million yuan in a new electronic-grade phosphoric acid project [14] - Jiaao Environmental Protection's stock will be subject to risk warnings due to an administrative penalty [15] - ST Nuotai received a drug registration certificate for a new injection [16] Group 6 - Haimo Technology plans to sell its controlling subsidiary, Xian Sitian Instrument, for 370 million yuan [17] - Jingce Electronics signed multiple sales contracts with a single customer totaling 433 million yuan [18] - Donghua Testing's controlling shareholder plans to reduce its stake by up to 1.99% [19][20] Group 7 - Xingqi Eye Medicine completed the first subject enrollment for a Phase II clinical trial of its eye drop product [21] - Kute Intelligent's controlling shareholder plans to reduce its stake by up to 2% [22] - Dongcheng Pharmaceutical's subsidiary received approval for a new specification of a heparin sodium injection [23] Group 8 - Zhaoyi Innovation is in the process of issuing H-shares and has received regulatory approval [24] - Aokang International's shareholder plans to reduce its stake by up to 3% [25] - Jiamei Packaging's controlling shareholder is planning a change of control, leading to a temporary stock suspension [26] Group 9 - ST Kevin's stock will have its risk warning lifted and will resume trading [27] - Zaiseng Technology's controlling shareholder plans to transfer 6.04% of the company's shares [28] - Lide New Energy's shareholder plans to reduce its stake by up to 1% [29] Group 10 - Srypu terminated its plan to acquire shares and will resume trading [30] - Longjiang Transportation's subsidiary plans to invest 2.679 billion yuan in a graphite mining project [31] - Haowei Group's controlling shareholder has not reduced its stake and has terminated the reduction plan [32] Group 11 - Huilun Crystal received an administrative penalty notice for information disclosure violations [33] - Haiguang Information terminated a major asset restructuring plan [34] - Zhongke Shuguang announced a cash dividend plan [35] Group 12 - Fushuo Technology's share purchase plan was approved by the Shenzhen Stock Exchange [36] - Dongbai Group's shareholder reduced its stake by 25.95 million shares [38]

Group 1 - Zhongke Shuguang announced the termination of the major asset restructuring plan involving Haiguang Information due to significant changes in market conditions and prolonged discussions, which will not adversely affect the company's operations and financial status [2] - Huilun Crystal's stock will be subject to risk warnings due to false records in its 2021 and 2022 annual reports, changing its trading name to "ST Huilun" [3] - SIRUI decided to terminate the acquisition of shares in Ningbo Aola Semiconductor, with its stock set to resume trading [4] Group 2 - ST Kevin's stock will resume trading after the removal of risk warnings, changing its name to "Caesar Culture" and adjusting the daily trading limit from 5% to 10% [5] - Jiamei Packaging announced that its controlling shareholder is planning a change in control, leading to a temporary suspension of its stock [6] - Zai Sheng Technology's controlling shareholder plans to transfer 6.04% of the company's shares to Zhongrong Huaxin for a total price of 344 million yuan [7] Group 3 - Xingfu Electronics plans to invest 480 million yuan in a project to build a 40,000 tons/year electronic-grade phosphoric acid facility, expected to start construction on December 15, 2025 [8] - Jiaao Environmental Protection received an administrative penalty notice, leading to risk warnings on its stock, which will change its name to "ST Jiaao" [9] - Longi Green Energy decided to terminate its overseas issuance of Global Depositary Receipts (GDR) due to changes in external factors [10] Group 4 - Yingpais announced that its controlling shareholder plans to increase its stake in the company by 60 million to 120 million yuan [12] - Aokang International's shareholder plans to reduce its stake by up to 3% due to personal financial needs [13] - Shenzhou Information's controlling shareholder plans to reduce its stake by up to 2.95% [14] Group 5 - Bai'ao Intelligent is pre-bidding for a project worth 27.5 million yuan with a large state-owned company [16] - Jingce Electronics received orders for semiconductor testing equipment totaling approximately 433 million yuan [17] - ST Weihai, in a joint venture, won a bid for a smart agriculture project worth 652 million yuan, representing 26.27% of its audited revenue for 2024 [18]

北京商报讯（记者 张君花）12月9日电，奥康国际发布公告称，股东项今羽因个人资金需求，拟通过集 中竞价和大宗交易方式合计减持不超过1200万股，占公司总股本的3%。其中，集中竞价减持不超过400 万股，大宗交易减持不超过800万股。减持期间为2025年12月31日至2026年3月30日。项今羽当前持有公 司7.14%股份，来源为协议转让取得。 ...

Shareholder Reduction - Shandong Electric Power Construction plans to reduce its stake in Liyuan New Energy by 1% [1] - Chiyao Investment and its concerted parties intend to reduce their holdings in Haomei New Materials by no more than 0.4404% [1] - Shareholder Xiang Jinyu of Aokang International aims to reduce his stake by no more than 3% [1] - The controlling shareholder of Donghua Testing and its concerted parties plan to reduce their holdings by no more than 1.99% [1] - The actual controller's concerted parties of Kute Intelligent plan to reduce their stake by no more than 2% [1] - Runke Investment intends to reduce its stake in Meixin Technology by no more than 1.6047% [1] - Guochuang Kaiyuan plans to reduce its holdings in Shanshi Network Technology by no more than 180.24 million shares [1] - The controlling shareholder of Shenzhou Information intends to reduce its stake by no more than 2.9543% [1] - Shareholder Wang Donghui of Juguang Technology plans to reduce 2.6958 million shares [1] - Shareholder Fan Jianhua of Dingxin Communications has completed the reduction of 2 million shares [1] - Shareholder Ouyang Ruiqun of Wanlang Magnetic has reduced 1.5984 million shares [1] - Shareholder Guangxin Group of Shengyi Technology has reduced 12.9101 million shares [1] - Advanced Manufacturing Fund and Beijing-Tianjin-Hebei Fund collectively reduced 1.03% of their holdings in Tianzhihang [1] Other Corporate Actions - SIRUI Technology has terminated its major asset restructuring plan and its stock has resumed trading [1] - ST Meichen and its wholly-owned subsidiary have been included in the list of dishonest executors [1]